Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Chase

Showing results (131-140 of 397) with videos related to

Pageof 40
Sort By:
The New England Journal of Medicine|April 23, 1970
Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of GuamJ A Brody, T N Chase, E K Gordon
Neuropharmacology|May 1, 1970
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disordersT N Chase, J A Schnur, E K Gordon
Lancet (London, England)|March 21, 1970
Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolismJ R Mendell, W K Engel, T N Chase
Archives of Neurology|July 1, 1989
Memory impairment in patients with progressive supranuclear palsyI Litvan, J Grafman, C Gomez, et al.
Brain Research|March 30, 1973
Dopamine histofluorescence: restoration in mammalian brain tissues prepared several hours post mortemT S Balch, T N Chase, D M Jacobowitz
European Journal of Pharmacology|January 11, 1996
Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonistsJ J Anderson, A M Kask, T N Chase
The American Journal of Psychiatry|June 1, 1978
Muscimol: GABA agonist therapy in schizophreniaC A Tamminga, J W Crayton, T N Chase
Archives of General Psychiatry|May 1, 1979
Improvement in tardive dyskinesia after muscimol therapyC A Tamminga, J W Crayton, T N Chase
The New England Journal of Medicine|November 14, 1985
Reduced brain somatostatin levels in Alzheimer's diseaseC A Tamminga, N L Foster, T N Chase
Neurology|August 26, 1998
Neostriatal mechanisms in Parkinson's diseaseT N Chase, J D Oh, P J Blanchet
Pageof 40

Showing results (131-140 of 397) with videos related to

Sort By:
Pageof 40
The New England Journal of Medicine|April 23, 1970
Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of GuamJ A Brody, T N Chase, E K Gordon
Neuropharmacology|May 1, 1970
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disordersT N Chase, J A Schnur, E K Gordon
Lancet (London, England)|March 21, 1970
Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolismJ R Mendell, W K Engel, T N Chase
Archives of Neurology|July 1, 1989
Memory impairment in patients with progressive supranuclear palsyI Litvan, J Grafman, C Gomez, et al.
Brain Research|March 30, 1973
Dopamine histofluorescence: restoration in mammalian brain tissues prepared several hours post mortemT S Balch, T N Chase, D M Jacobowitz
European Journal of Pharmacology|January 11, 1996
Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonistsJ J Anderson, A M Kask, T N Chase
The American Journal of Psychiatry|June 1, 1978
Muscimol: GABA agonist therapy in schizophreniaC A Tamminga, J W Crayton, T N Chase
Archives of General Psychiatry|May 1, 1979
Improvement in tardive dyskinesia after muscimol therapyC A Tamminga, J W Crayton, T N Chase
The New England Journal of Medicine|November 14, 1985
Reduced brain somatostatin levels in Alzheimer's diseaseC A Tamminga, N L Foster, T N Chase
Neurology|August 26, 1998
Neostriatal mechanisms in Parkinson's diseaseT N Chase, J D Oh, P J Blanchet
Pageof 40